SARS-CoV-2 infection in patients with primary mitochondrial diseases: Features and outcomes in Italy-Reference-Cited by-同舟云学术

SARS-CoV-2 infection in patients with primary mitochondrial diseases: Features and outcomes in Italy

Published:2021-05 Issue: Volume:58 Page:243-245
ISSN:1567-7249
Container-title:Mitochondrion
language:en
Short-container-title:Mitochondrion

Author:

Mancuso Michelangelo^ORCID,La Morgia Chiara,Valentino Maria Lucia,Ardissone Anna,Lamperti Costanza,Procopio Elena^ORCID,Garone Caterina,Siciliano Gabriele,Musumeci Olimpia,Toscano Antonio,Primiano Guido,Servidei Serenella,Carelli Valerio

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Molecular Medicine

Reference7 articles.

1. Mitochondrial diseases;Gorman;Nat. Rev. Dis Prim.,2016

2. Updated rapid risk assessment from ECDC on coronavirus disease 2019 (COVID-19) pandemic: increased transmission in the EU/EEA and the UK;None;Eurosurveillance,2020

3. Mancuso, M., McFarland, R., Klopstock, T., et al. International Workshop:: Outcome measures and clinical trial readiness in primary mitochondrial myopathies in children and adults. Consensus recommendations. 16–18 November 2016, Rome, Italy. In: Neuromuscular Disorders. ; 2017. doi:10.1016/j.nmd.2017.08.006.

4. Mitochondrial diseases in North America: an analysis of the NAMDC Registry;Barca;Neurol. Genet.,2020

5. Neurological associations of COVID-19;Ellul;Lancet Neurol.,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Symptomatic SARS-CoV-2 Infection with Ageusia after Two mRNA Vaccine Doses;International Journal of Environmental Research and Public Health;2022-01-13

3. Mitochondrial Medicine in the COVID-19 Era;Journal of Clinical Medicine;2021-11-10